Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The TQCC of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Immunoscore and its introduction in clinical practice47
The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors33
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study13
The emerging value of 64Cu for molecular imaging and therapy11
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma11
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors10
Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin9
Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer9
Applicability of sentinel lymph node biopsy in papillary thyroid cancer9
Lung shunt and lung dose calculation methods for radioembolization treatment planning9
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging9
Fully integrated [18F]FDG PET/MR in large vessel vasculitis8
Nuclear medicine radiomics in precision medicine: why we can't do without artificial intelligence8
Evaluation of physiologic and abnormal glucose uptake in palatine tonsils: differential diagnostics with sequential dual-time-point 2-deoxy-2-[18F]FDG PET/CT8
Practice and prospects for PET/CT guided interventions8
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study7
PSMA uptake on [68Ga]-PSMA-11-PET/CT positively correlates with prostate cancer aggressiveness7
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging7
Update on tumor metabolism and patterns of response to immunotherapy6
The role of PET imaging in inflammatory bowel diseases: state-of-the-art review6
IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications6
Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols6
Beta radioguided surgery: towards routine implementation?6
Interventional nuclear medicine: a focus on radioguided intervention and surgery6
Copper, PET/CT and prostate cancer: a systematic review of the literature5
Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions5
Functional and molecular thyroid imaging5
An essential practice summary of the new EANM guidelines for parathyroid imaging5
Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-2255
Radioiodine therapy of Graves' disease5
PET- and SPECT-based navigation strategies to advance procedural accuracy in interventional radiology and image-guided surgery5
The role of laboratory medicine in the diagnosis of the hyperthyroidism4
Therapeutic applications of radioactive sources: from image-guided brachytherapy to radio-guided surgical resection4
Radioiodine therapy of thyroid autonomy4
Integration of molecular imaging in the personalized approach of patients with adrenal masses4
18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion?4
Theragnostic radionuclides: a clinical perspective4
Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy4
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?4
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization4
Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature4
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?4
Efficient 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based machine learning model for predicting epidermal growth factor receptor mutations in non-small cell lung cancer4
Update on diagnosis and treatment of hyperthyroidism: ultrasonography and functional imaging4
0.021085023880005